Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study

BACKGROUND: The purpose of this study was to analyze the efficacy and safety of concurrent chemoradiotherapy combined with Nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma (NPC). METHODS: This study included 49 low-risk T4 stage NPC patients treated with concurrent chemoradiotherapy plus N...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Zhang, Shuai, huang, Xiaopeng, Zhou, Liya, Lin, Shaomin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160225/
https://ncbi.nlm.nih.gov/pubmed/30235761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012503
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak